Levothyroxine Sodium Tablet
Product Images NDC 51655-923

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-923). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (449d2ef9 3580 46c8 8fe5 5d81cb18e40f 01)

Chemical structure diagram of Levothyroxine Sodium, depicting the molecular arrangement of atoms including iodine, sodium ion (Na+), hydroxyl group (OH), and water of hydration (xH2O).*

FDA Label Image

Label (51655 923 52 Master Bottle Label Approval Rev A 03 22)

Label for Levothyroxine Sodium Tablets USP 100 mcg (0.1 mg), packaged as 30 tablets. The label includes storage instructions, dosage form, strength, and prescription status. It also mentions the labeler, Northwind Pharmaceuticals, Inc., and display barcodes and lot information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.